Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 16714-534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 16714-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

122 (Emtricitabine And Tenofovir Disoproxil Fumrate Label)

122 (Emtricitabine And Tenofovir Disoproxil Fumrate Label)
This is a description of a medication called Emtricitabine and Tenofovir Disoproxil Fumarate Tablets with a strength of 200mg/300mg per tablet. The medication contains 200mg of emtricitabine and 300mg of tenofovir disoproxil fumarate per tablet. The dosage information can be found in the prescribing information. The medication guide should be provided separately to each patient. The tablets come in an original container of 30 tablets. The medication should be stored below 30°C (86°F) and the container should be tightly closed. The NorthStar Rx LLC manufactured the medication in Memphis, TN, and it was manufactured by Macleods Pharmaceuticals Ltd. in Daman, India. For more information, visit www.northstarrxlic.com/products or call 1-800-206-7821.*
FDA Label Image

123 (Structure Emtricitabine)

FDA Label Image

134 (Structure Tenofovir)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.